You are here


Award Information
Agency: National Science Foundation
Branch: N/A
Contract: 0109733
Agency Tracking Number: 0109733
Amount: $100,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Solicitation Year: N/A
Award Year: 2001
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
673 G Alpha Drive
Cleveland, OH 44143
United States
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Frederick Lisy
 (440) 449-5785
Business Contact
 Frederick Lisy
Title: Vice President
Phone: (440) 449-5785
Research Institution

This Small Business Innovative Research (SBIR) Phase I project will develop a novel and flexible, dry, physiological recording electrode that conforms to non-planar surfaces and does not require extensive surface preparation or conductive gels to achieve a low impedance interface with the body. This innovative electrode will be fabricated inexpensively using microfabrication techniques and priced competitively with existing commercial electrodes despite its enhanced performance and features. The proposed dry electrode will provide substantial improvement in all areas of biomedical research and medicine that involve use of electro- physiological potentials such as EEG, EMG, EOG, and ECG signals. This unique electrode is particularly well suited for long-term and multiple electrode physiological monitoring as compared to existing commercial electrodes,since multiple electrodes can be easily fabricated into a single array with a common connector, thereby simplifying application. Additionally, by providing a low impedance interface with the body, this electrode will eliminate the need for an electrolytic gel or the need to abrade the skin prior to applying the electrode.
The commercial applications of this project will follow directly from the development of the novel electrode (Orbital Research Dry Physiological Recording Electrode) that seeks to improve electro-physiological signal quality (for EEGs, EMGs, ECGs or EOGs), eliminates the harsh side effects and signal deterioration common with existing electrodes and is competitively priced. By enhancing quality of life at no additional cost, this biomedical innovation is expected to lead to new long-term monitoring applications.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government